Frontal fibrosing alopecia severity index (FFASI): a validated scoring system for assessing frontal fibrosing alopecia Running title: Frontal fibrosing alopecia severity index (FFASI) 
A British Hair and Nail Society (BHNS) subgroup considered clinical methods of assessing FFA severity and activity. In agreement with other authors 4, 7 , assessment of alopecia band width was deemed the most appropriate and objective measurement of severity, with changes in extent over time reflecting disease activity. FFASI was compiled in two forms: FFASI and FFASI B (figure 1).
FFASI utilises clinical images of the entire hairline, divided into 4 sections. Alopecia severity is graded 1-5 based on hairline recession similar to criteria proposed by Vano Galvan 4 . In order that hairline recession comprises the greatest proportion of the assessment, each grade is weighted. Although of uncertain significance 1, 2, 8 , frontal band inflammation is also assessed. Non-scalp hair loss 5 (eyebrow, eyelash, limb and flexural) are scored, as are associated features (facial papules 2, 9 ; cutaneous 2,4 , nail 10 and mucosal LP 1, 2, 4 ; and generalised scalp LPP 1, 4 ). Scores for hairline recession, inflammatory band, non-scalp loss and associated features may be combined to give a maximum score of 100.
FFASIB uses the same format but rather than grading alopecia, permits user-defined measurement of each hairline section. FFASIB was not validated in this exercise. For assessment of patient photographs using FFASI, intra-observer concordance showed strong to very strong agreement for all hairline areas, indicating consistency in assessments by individual consultants (supplementary 
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FFASI is weighted in favour of hairline assessment as alopecia is the principle feature. However, a total score out of 100 can be calculated, representing global disease severity. Initially considered a scalp disorder, both facial and body hair are frequently lost 5 and may sometimes predate onset of scalp loss 4 . Facial vellus follicle involvement results in facial papules 2, 9 . Cutaneous, mucosal and nail LP, and generalised scalp LPP are infrequently associated 1, 2, 4, 10 . The natural history is unclear and it is uncertain how the condition progresses. Involvement of the frontal hairline seems universal 4 . Loss of eyelashes and facial papules are associated with more severe disease 4 .
FFA treatments need to be assessed by clinical trials. Many treatments have been used but as evidence is weak (no RCTs, variable outcome measures etc.), it is difficult to assess superiority of efficacy 7, 13 . To have confidence in trial results, a standardised, validated and objective assessment method is required. To date, several non-standardised and non-validated methods have been used.
The most frequent method is measurement from nasal crease to frontal hairline or other forehead/frontal hairline measures 1,2 . Although helpful for measuring change in a patient over time, this is less helpful when comparing between patients due to differing pre-morbid hairline positions.
Detailed photographic images are an accurate means of monitoring disease however, they do not permit statistical analysis. LPPAI was devised as an assessment tool for LPP activity 14 . It includes scoring of symptoms and signs of inflammation, positive anagen-pull and disease spreading, with results calculated using a devised formula. It has been criticised for being based on subjective data calculated using an arbitrary formula 15 , and gives no account of extent of hair already lost. FFASI offers a more complete assessment of the hairline than point measurement(s) and provides numerical data that can be analysed statistically. It does not rely unduly on measures of uncertain significance (symptoms, erythema or anagen-pull), but measures the cardinal disease feature, extent of alopecia.
Additionally, it allows global disease assessment by including facial and body hair, and associated features.
Change in FFASI grade over time reflects disease activity and the standardised format allows comparison between patients. One weakness of FFASI is that it relies upon a "best-fit" model for grading alopecia band width: bands of recession are not entirely uniform and clinical judgement is required. However, more precise assessment can be made by recording actual band width measurements using FFASI B. In conclusion, we have a developed a validated scoring system for
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FFA which allows global disease assessment for individuals over time and permits comparison between patients.
